These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Pharmaceutical innovation in the United States. Factors affecting future performance. Pollard MR Int J Technol Assess Health Care; 1993; 9(2):167-73. PubMed ID: 8458697 [TBL] [Abstract][Full Text] [Related]
4. Realizing two-tiered innovation policy through drug regulation. Ridgway WE Stanford Law Rev; 2006 Feb; 58(4):1221-50. PubMed ID: 16685807 [No Abstract] [Full Text] [Related]
5. Innovation and compliance are not diametrically opposed. Raab GK Qual Assur; 1994 Mar; 3(1):2-8. PubMed ID: 7804614 [No Abstract] [Full Text] [Related]
6. Does Increased Spending on Pharmaceutical Marketing Inhibit Pioneering Innovation? Arnold DG; Troyer JL J Health Polit Policy Law; 2016 Apr; 41(2):157-79. PubMed ID: 26732315 [TBL] [Abstract][Full Text] [Related]
7. Deconstructing the drug development process: the new face of innovation. Kaitin KI Clin Pharmacol Ther; 2010 Mar; 87(3):356-61. PubMed ID: 20130565 [TBL] [Abstract][Full Text] [Related]
8. Who is the beneficiary? Akers JE PDA J Pharm Sci Technol; 1999; 53(4):155-6. PubMed ID: 10754706 [No Abstract] [Full Text] [Related]
9. Therapeutics, drug pricing and innovation. Somberg J Am J Ther; 2003; 10(6):381. PubMed ID: 14624273 [No Abstract] [Full Text] [Related]
10. Location of pharmaceutical innovation: 2000-2009. Friedman Y Nat Rev Drug Discov; 2010 Nov; 9(11):835-6. PubMed ID: 21030994 [No Abstract] [Full Text] [Related]
11. Most prescribed pharmaceuticals. Mod Healthc; 2013 Jul; 43(28):34. PubMed ID: 24044238 [No Abstract] [Full Text] [Related]
12. When drugs are in short supply. Zurlinden J Nurs Spectr (Wash D C); 1999 Feb; 9(4):15-6. PubMed ID: 10542818 [No Abstract] [Full Text] [Related]
13. The FDA and the pharmaceutical industry: is regulation contributing to drug shortage? Roman A Albany Law Rev; 2013-2014; 77(2):539-77. PubMed ID: 24851322 [No Abstract] [Full Text] [Related]
14. Drugs that made headlines in 2016. Keener AB Nat Med; 2016 Dec; 22(12):1377-1379. PubMed ID: 27923025 [No Abstract] [Full Text] [Related]
15. How to handle an industry in disruption: Intervene or laissez-faire? Munos B Sci Transl Med; 2015 May; 7(286):286ps12. PubMed ID: 25947160 [TBL] [Abstract][Full Text] [Related]
16. Public policy and pharmaceutical innovation. Grabowski HG Health Care Financ Rev; 1982 Sep; 4(1):75-87. PubMed ID: 10309721 [TBL] [Abstract][Full Text] [Related]
17. Did Medicare Induce Pharmaceutical Innovation? Acemoglu D; Cutler D; Finkelstein A; Linn J Am Econ Rev; 2006 May; 96(2):103-7. PubMed ID: 29131561 [No Abstract] [Full Text] [Related]
18. [Biopharmaceutical industry's commitment to innovation and to the future of health care]. Marini G Recenti Prog Med; 2006 Nov; 97(11):626-33. PubMed ID: 17252719 [TBL] [Abstract][Full Text] [Related]
19. Emerging technology: A key enabler for modernizing pharmaceutical manufacturing and advancing product quality. O'Connor TF; Yu LX; Lee SL Int J Pharm; 2016 Jul; 509(1-2):492-498. PubMed ID: 27260134 [TBL] [Abstract][Full Text] [Related]